PE20020959A1 - Derivados quimicos y su aplicacion como agentes antitelomerasa - Google Patents
Derivados quimicos y su aplicacion como agentes antitelomerasaInfo
- Publication number
- PE20020959A1 PE20020959A1 PE2002000227A PE2002000227A PE20020959A1 PE 20020959 A1 PE20020959 A1 PE 20020959A1 PE 2002000227 A PE2002000227 A PE 2002000227A PE 2002000227 A PE2002000227 A PE 2002000227A PE 20020959 A1 PE20020959 A1 PE 20020959A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- nil
- methyl
- triazine
- quinoli
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- -1 AMINO Chemical class 0.000 abstract 3
- XNMYNYSCEJBRPZ-UHFFFAOYSA-N 2-[(3-butyl-1-isoquinolinyl)oxy]-N,N-dimethylethanamine Chemical compound C1=CC=C2C(OCCN(C)C)=NC(CCCC)=CC2=C1 XNMYNYSCEJBRPZ-UHFFFAOYSA-N 0.000 abstract 2
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 abstract 1
- KCZIUKYAJJEIQG-UHFFFAOYSA-N 1,3,5-triazin-2-amine Chemical compound NC1=NC=NC=N1 KCZIUKYAJJEIQG-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003277 telomerase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN AGENTE REPARTIDOR LIGADO A GRUPOS AMINO AROMATICOS DE FORMULA: CICLOAROMATICO NITROGENADO-NR3-DISTRIBUIDOR-NR'3-CICLO AROMATICO; DONDE CICLOAROMATICO NITROGENADO ES QUINOLEINA, ISOQUINOLEINA, BENZAMIDINA, PIRIDINA; CICLO AROMATICO REPRESENTA QUINOLEINA SUSTITUIDO POR N(Ra)(Rb); BENZAMIDINA, PIRIDINA, FENILO, HETEROCICLO MONO, BI, TRICICLICO; Ra, Rb SON H, ALQUILO C1-C4, ALCOXI C1-C4. R3, R'3 SON TRIAZINA SUSTITUDO, DIAZINA SUSTITUIDO. SON COMPUESTOS PREFERIDOS 2,4-BIS-(4-DIMETILAMINO-2-METIL-QUINOLI-6-NIL)AMINO-6-(3-DIMETILAMINO-PROPIL)AMINO-[1,3,5]TRIAZINA; 2,4,6-TRIS-(4-AMINO-2-METIL-QUINOLI-6-NIL)AMINO-[1,3,5]TRIAZINA, 2,4-BIS-(4-AMINO-2-METIL-QUINOLI-6-NIL)AMINO-6-(4-DIMETILAMINO-2-METIL-QUINOLI-6-NIL)-AMINO-[1,3,5]TRIAZINA, 2,4-BIS-(4-DIMETILAMINO-2-METIL-QUINOLI-6-NIL)AMINO-6-((1-METIL-PIPERIDI-4-NIL)-[1,3,5]TRIAZINA, ENTRE OTROS. LOS COMPUESTOS NO NUCLEOTIDOS INTERACTUAN CON ESTRUCTURAS ESPECIFICAS DEL ADN O ARN, SON INHIBIDORES DE TELOMERASA VIA LA ESTABILIZACION DE G-CUADRUPLEXAS, Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE CANCER
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0103916A FR2822468B1 (fr) | 2001-03-23 | 2001-03-23 | Derives chimiques et leur application comme agent anti-telomerase |
| FR0110370 | 2001-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020959A1 true PE20020959A1 (es) | 2002-12-17 |
Family
ID=26212933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000227A PE20020959A1 (es) | 2001-03-23 | 2002-03-22 | Derivados quimicos y su aplicacion como agentes antitelomerasa |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1373252A1 (es) |
| JP (1) | JP2004524349A (es) |
| AR (1) | AR034297A1 (es) |
| AU (1) | AU2002251140B2 (es) |
| CA (1) | CA2442012A1 (es) |
| CO (1) | CO5380035A1 (es) |
| IL (2) | IL158056A0 (es) |
| MX (1) | MXPA03008269A (es) |
| MY (1) | MY130957A (es) |
| PE (1) | PE20020959A1 (es) |
| WO (1) | WO2002076975A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1401833A2 (fr) | 2001-05-28 | 2004-03-31 | Aventis Pharma S.A. | Derives chimiques et leur application comme agent antitelomerase |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| WO2003055866A1 (en) * | 2001-12-21 | 2003-07-10 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| WO2004001018A2 (en) * | 2002-06-25 | 2003-12-31 | The Center For Blood Research, Inc. | Vacuolins |
| FR2850970B1 (fr) * | 2003-02-07 | 2006-07-07 | Aventis Pharma Sa | Derives chimiques se liant de maniere tres specifique aux structures d'adn en g-quadruplexe et leur application comme agent anticancereux specifique |
| AU2004253967B2 (en) | 2003-07-03 | 2010-02-18 | Cytovia, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| WO2006122431A1 (en) * | 2005-05-19 | 2006-11-23 | Prometic Biosciences Inc. | Triazine compounds and compositions thereof for the treatment of cancers |
| EP2046763A2 (en) * | 2006-07-31 | 2009-04-15 | Praecis Pharmaceuticals Incorporated | Aurora kinase inhibitors from an encoded small molecule library |
| JP5282091B2 (ja) * | 2007-07-25 | 2013-09-04 | ブリストル−マイヤーズ スクイブ カンパニー | トリアジンキナーゼ阻害剤 |
| FR2948686B1 (fr) * | 2009-07-30 | 2011-08-19 | Biomerieux Sa | Nouveaux substrats de peptidase |
| US20210024455A1 (en) * | 2018-03-20 | 2021-01-28 | Hiroshima University | Compound which inhibits telomere-binding protein, and telomere-binding protein inhibitor containing same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206768D0 (en) * | 1992-03-27 | 1992-05-13 | Jarman Michael | New compounds for use in the treatment of cancer |
| JPH1160573A (ja) * | 1997-08-22 | 1999-03-02 | Nippon Kayaku Co Ltd | トリアジン誘導体及びテロメラーゼ阻害剤 |
| US6262053B1 (en) * | 1999-06-23 | 2001-07-17 | Parker Hughes Institute | Melamine derivatives as potent anti-cancer agents |
| DK1244650T3 (da) * | 1999-11-29 | 2003-10-20 | Aventis Pharma Sa | Arylaminderivater og deres anvendelse som antitelomerasemidler |
| ATE511858T1 (de) * | 2002-02-05 | 2011-06-15 | Astellas Pharma Inc | 2,4,6-triamino-1,3,5-triazin-derivat |
-
2002
- 2002-03-21 CO CO02025874A patent/CO5380035A1/es not_active Application Discontinuation
- 2002-03-22 MX MXPA03008269A patent/MXPA03008269A/es not_active Application Discontinuation
- 2002-03-22 CA CA002442012A patent/CA2442012A1/fr not_active Abandoned
- 2002-03-22 AR ARP020101060A patent/AR034297A1/es unknown
- 2002-03-22 JP JP2002576233A patent/JP2004524349A/ja not_active Ceased
- 2002-03-22 IL IL15805602A patent/IL158056A0/xx unknown
- 2002-03-22 MY MYPI20021036A patent/MY130957A/en unknown
- 2002-03-22 AU AU2002251140A patent/AU2002251140B2/en not_active Ceased
- 2002-03-22 PE PE2002000227A patent/PE20020959A1/es not_active Application Discontinuation
- 2002-03-22 EP EP02720068A patent/EP1373252A1/fr not_active Withdrawn
- 2002-03-22 WO PCT/FR2002/001005 patent/WO2002076975A1/fr not_active Ceased
-
2003
- 2003-09-22 IL IL158056A patent/IL158056A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1373252A1 (fr) | 2004-01-02 |
| MXPA03008269A (es) | 2004-10-15 |
| CO5380035A1 (es) | 2004-03-31 |
| IL158056A0 (en) | 2004-03-28 |
| MY130957A (en) | 2007-07-31 |
| AU2002251140B2 (en) | 2007-03-15 |
| AR034297A1 (es) | 2004-02-18 |
| IL158056A (en) | 2010-02-17 |
| CA2442012A1 (fr) | 2002-10-03 |
| WO2002076975A1 (fr) | 2002-10-03 |
| JP2004524349A (ja) | 2004-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020959A1 (es) | Derivados quimicos y su aplicacion como agentes antitelomerasa | |
| PE20191613A1 (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret | |
| PE20010912A1 (es) | Derivados arilamina y su aplicacion como agentes antitelomerasa | |
| DE602004026047D1 (de) | Hemmer der akt aktivität | |
| BRPI0514371A (pt) | 2, 4 di (aminofenil) pirimidina como inibidores de plk | |
| GEP20053660B (en) | Novel Tyrosine Kinase Inhibitors | |
| ATE446752T1 (de) | Hemmer der akt aktivität | |
| DE60227492D1 (de) | Hemmstoffe der akt aktivität | |
| AR029383A1 (es) | Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes | |
| PA8537501A1 (es) | Naftostirilos | |
| ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
| CO5700778A2 (es) | Administracion combinada de una indolinona con un agente quimioterapeutico para trastornos de proliferacion celular | |
| PE20010211A1 (es) | Compuestos de tiazol y composiciones farmaceuticas para inhibir las quinasas de proteina | |
| PA8501801A1 (es) | Inhibidores triciclicos de polimerasas (adp - polirribosas) | |
| CO5540312A2 (es) | Derivados de imidazo 1,2-a-piridina para la profilaxis y el tratamiento de infecciones virales por herpes | |
| ES2172945T3 (es) | Imidazotriazinonas sustituidas en 2 con fenilo como inhibidores de fosfodiesterasas. | |
| GT200100016A (es) | Pirido[2,3,-d]pirimidin-2,7-diaminas inhibidoras de cinasas. | |
| AP2000002016A0 (en) | 2-(Purin-9-yl) Tetrahydrofuran-3,4-diol derivatives. | |
| EP1633740A4 (en) | CHEMICAL COMPOUNDS | |
| SE9702564D0 (sv) | New compounds | |
| DK1483251T3 (da) | C3-cyano-epothilon-derivater | |
| MXPA03008635A (es) | Compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
| AR029005A1 (es) | FORMULACION LíQUIDA ESTABLE SIN AGUA O CASI SIN AGUA DE BENCIMIDAZOLES SUSTITUIDOS, PROCESO PARA SU PREPARACIoN, USO DE ESTA FORMULACIoN, Y USO DE POLIETILENGLICOL Y UNA SAL DE SODIO O POTASIO DE UN INHIBIDOR DE H+, K+-ATP ASA | |
| BG108180A (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| GT200100251A (es) | Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |